1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase 2 clinical trial of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcomas
    Journal Article

    Attia, S.; Villalobos, V.; Hindi, N.; Wagner, A. J.; Chmielowski, B.; Oakley, G. J. 3rd; Peterson, P. M.; Ceccarelli, M.; Jones, R. L.; Dickson, M. A.
    Cancers (2023)

    Fulltext@MSK | Save
  • Impact of liver cirrhosis, the severity of cirrhosis, and portal hypertension on the outcomes of minimally invasive left lateral sectionectomies for primary liver malignancies
    Journal Article

    Coelho, F. F.; Herman, P.; Kruger, J. A. P.; Wu, A. G. R.; Chin, K. M.; Hasegawa, K.; Zhang, W.; Alzoubi, M.; Aghayan, D. L.; Siow, T. F.; more...
    Surgery (2023)

    Fulltext@MSK | Save
  • Sub-classification of laparoscopic left hepatectomy based on hierarchic interaction of tumor location and size with perioperative outcomes
    Journal Article

    Ruzzenente, A.; Valle, B. D.; Poletto, E.; Syn, N. L.; Kabir, T.; Sugioka, A.; Cipriani, F.; Cherqui, D.; Han, H. S.; Armstrong, T.; more...
    Journal of Hepato - Biliary - Pancreatic Surgery (Japan) (2023)

    Fulltext@MSK | Save
  • Intraocular methotrexate for epithelial downgrowth: Long-term outcomes in a multicentre case series
    Journal Article

    Hébert, M.; Kyrillos, R.; Snyder, M. E.; Mackool, R. J.; Francis, J. H.; Wu, H. K.; Riemann, C. D.; Légaré, M. E.
    British Journal of Ophthalmology (2023)

    Fulltext@MSK | Save
  • Impact of tumor size on the difficulty of laparoscopic major hepatectomies: An international multicenter study
    Journal Article

    Kato, Y.; Sugioka, A.; Kojima, M.; Syn, N. L.; Zhongkai, W.; Liu, R.; Cipriani, F.; Armstrong, T.; Aghayan, D. L.; Siow, T. F.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • CRISPR-Cas9 editing of the HBG1 and HBG2 promoters to treat sickle cell disease
    Journal Article

    Sharma, A.; Boelens, J. J.; Cancio, M.; Hankins, J. S.; Bhad, P.; Azizy, M.; Lewandowski, A.; Zhao, X.; Chitnis, S.; Peddinti, R.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
    Journal Article

    Pignata, S.; Bookman, M.; Sehouli, J.; Miller, A.; Penson, R. T.; Taskiran, C.; Anderson, C.; Hietanen, S.; Myers, T.; Madry, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Phase 3 CLEAR study in patients with advanced renal cell carcinoma: Outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
    Journal Article

    Grünwald, V.; Powles, T.; Eto, M.; Kopyltsov, E.; Rha, S. Y.; Porta, C.; Motzer, R.; Hutson, T. E.; Méndez-Vidal, M. J.; Hong, S. H.; more...
    Frontiers in Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors
    Journal Article

    Abuzakhm, S. M.; Sukrithan, V.; Fruth, B.; Qin, R.; Strosberg, J.; Hobday, T. J.; Semrad, T.; Reidy-Lagunes, D.; Kindler, H. L.; Kim, G. P.; more...
    Endocrine-Related Cancer (2023)

    Fulltext@MSK | Save
  • A phase Ib trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
    Journal Article

    Mascarenhas, J.; Migliaccio, A. R.; Kosiorek, H.; Bhave, R.; Palmer, J.; Kuykendall, A.; Mesa, R.; Rampal, R. K.; Gerds, A. T.; Yacoub, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save